Ekso Bionics Holdings, Inc., an industry leader in exoskeleton technology for medical and industrial use, announced the launch of GaitCoach™, its next generation gait therapy software for EksoNR.
GaitCoach is a comprehensive gait therapy software that supports a broad spectrum of patients who use EksoNR. This new software simplifies the use of robotics with the intention of improving user trust in technology, providing impactful, dynamic feedback and offering specific guidance acting as an extra set of clinical eyes. Ekso believes GaitCoach will reduce training demands and increase utilization, making the device more intuitive and easier to use for both patients and physical therapists. GaitCoach will replace SmartAssist, the software that has been in use since 2016 and was optimized in 2019 with the launch of EksoNR.
“By listening to the feedback of physical therapists, clinicians and patients, Ekso Bionics has elevated EksoNR with GaitCoach, a new software solution designed to further improve patient rehabilitation,” said Scott Davis, Chief Executive Officer of Ekso Bionics. “GaitCoach helps customize patient sessions to be better aligned with their deficits and goals, allowing therapists to treat patients more efficiently. We are proud of the work and commitment of our engineering and clinical teams, who communicated regularly with frequent users of EksoNR in the design process.”
When introduced to GaitCoach, experienced users of EksoNR have shared the following:
- 96% found GaitCoach software very or extremely intuitive
- 93% feel the guidance from GaitCoach is valuable and makes EksoNR easier to use
- 93% think EksoNR with GaitCoach would be useful for new or less experienced therapists at their clinic
- 93% feel the GaitCoach provided focuses would help them achieve their clinical goals
- 79% feel GaitCoach would help them progress their patients more easily
SOURCE: GlobeNewswire